Dan Rhodes, CEO at Strata Oncology, a tumor sequencing company, says genetic sequencing is “absolutely the bottleneck” in finding patients who will benefit from targeted cancer drugs. His company is giving away free testing to cancer patients to help match them to experimental treatments being studied in clinical trials (see “Should We Sequence the DNA of Every Cancer Patient?).

Read full article here